Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
In the C-terminal heptapeptide of cholecystokinin (-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2), replacing the aspartic acid residue by beta-aspartic acid did not alter the ability of the peptide to cause stimulation, desensitization, or residual stimulation of enzyme secretion from dispersed pancreatic acini. Replacing the tyrosine sulfate residue by hydroxynorleucine sulfate did not alter the ability of the heptapeptide to cause stimulation or desensitization, but caused a 50-fold decrease in the potency with which the peptide caused residual stimulation of enzyme secretion. These findings suggest that a modification of the N-terminal region of cholecystokinin heptapeptide, which does not alter the ability of the peptide to bind to its receptor on pancreatic acini and by so doing cause stimulation and desensitization of enzyme secretion, can increase the rate at which the bound peptide dissociates when the acini are washed and reincubated. This increased dissociation is reflected by a reduction in the potency with which the peptide causes residual stimulation of enzyme secretion.
D000681:Amylases / Q000378:metabolism; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002766:Cholecystokinin / Q000494:pharmacology*; D006168:Guinea Pigs; D007536:Isomerism; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology*; D010446:Peptide Fragments / Q000494:pharmacology*; D012844:Sincalide; D013329:Structure-Activity Relationship
D010446:Peptide Fragments; C025997:cholecystokinin (27-33); D001224:Aspartic Acid; D002766:Cholecystokinin; D000681:Amylases; D012844:Sincalide